Tremelimumab is under clinical development by AstraZeneca and currently in Phase II for Salivary Gland Cancer.

In a major step forward in the fight against HIV/AIDS, the US Food and Drug Administration (FDA) has approved Lenacapavir, an ...

South Africa spends over R30 billion annually on its HIV-Aids programs, which includes the costs of its extensive ART ...

Matthew Kavanagh, the director of Georgetown University's Centre for Global Health Policy & Politics and an advisor to the United Nations explains on the progress and challenges in the ...